Online ISSN: 2515-8260

Author : Anupama, Dr.

Acceptability and Compliance of DMPA in Patna Medical College and Hospital, Bihar.

Dr. Anupama

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 235-238

Introduction: In India, a large proportion of women with an unmet need for contraception are within their first year after childbirth. It is major obstacles for nation social and economic development. The present study concentrates to educate postpartum women for contraception and to study  the acceptance and compliance of medroxyprogesterone acetate (DMPA) in Bihar women .
Methods: This is retrospective study with cross sectional data collection from 210 patients for a period of 14 month , from JANUARY 2019 TO FEBRUARY 2020.
Results: The study concluded that DMPA is highly effective contraceptive with low failure rate .
Conclusion: It is available as a first line method to all who wish to opt reversible method of contraception.

Labetalol versus M-Lope in Treatment of Hypertensive Disorders of Injury – A Comparative Study

Dr. Anupama

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 2215-2217

Hypertensive disorders are one of  the commonest medical conditions complicating pregnancy. It complicates 5 to 10 percent of all pregnancy and accounts for approximately 16 percent of overall maternal deaths. In this study conducted at Patna Medical College Hospital, it was concluded that Labetalol is better antihypertensive that Methyl Dopa for use in pregnancy induced hypertension.

Sublingual Misoprostol for the Prevention of Postpartum Haemorrhage – A Randomised Control Trial

Dr. Anupama

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 4, Pages 2218-2221

Aim – The aim of the study was to study the effect of sublingual misoprostol for prevention of PPH.
Materials and Methods: This was a prospective, randomized, double blind, placebo controlled study. Inclusion criteria were women aged 20-40 years with 38-40 weeks of gestation who underwent elective caesarean section. Exclusion criteria were women have risk factors for post-partum haemorrhage, active thromboembolic disease and intrinsic risk for thrombosis. Participants were randomly assigned to misoprostol group or group A (n=50) and placebo group or group B(n=50). Group A received 400µg of sublingual misoprostol after delivery of the baby, group B received placebo tablet at the same time. Primary outcome measures were blood loss from delivery of the placenta to the end of the caesarean section to 2 hours postpartum, haemoglobin estimation was done in all patients pre operatively and 24 hours post operatively and the change in concentration was noted. Secondary outcome measures were need for additional uterotonics, use of additional surgical interventions to control post-partum haemorrhage.
Result: Blood loss from both placental delivery to the end of caesarean section and from end of caesarean section to 2 hours postpartum were significantly lower in the study group. (p<0.0001). Change in haemoglobin concentration in study group was also significantly less than in the control group. (p<0.0001). Total amount of Oxytocin required was significantly less in the study group (p=0.01). The number of women requiring other oxytocics (inj. Methyl ergometrine, inj. Carboprost) was significantly less in study group (p=0.0078). Conclusion – Sublingual misoprostol has been found to be effective in preventing PPH.

Fetomaternal Outcome in Cesarean Sections Done in Second Stage of Labor

Dr. Anupama

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 4895-4898

World-wide 10 to 20 % delivery require some form of interventions which include cesarean sections.  A prospective observational study was conducted at Patna Medical College Hospital comprised of 400 Cesarean sections included 22 sections performed in second stage of labor. It was concluded that Cesarean sections performed in second stage of labor were associated with increased mortality and morbidity.
Conclusion: Cesarean sections done on second stage of labor are associated with increased intra-operative maternal complications and neonatal morbidity.